Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55,482,166
-
Number of holders
-
52
-
Total 13F shares, excl. options
-
18,846,543
-
Shares change
-
-3,392,716
-
Total reported value, excl. options
-
$51,240,128
-
Value change
-
-$8,744,189
-
Put/Call ratio
-
48%
-
Number of buys
-
23
-
Number of sells
-
43
-
Price
-
$2.71
Institutional Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q4 2021
As of 31 Dec 2021 Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) had 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 18,846,543 shares of stock of the company.
Largest 10 holders included TRV GP III, LLC, EcoR1 Capital, LLC, VANGUARD GROUP INC, Erste Asset Management GmbH, FEDERATED HERMES, INC., ACADIAN ASSET MANAGEMENT LLC, JPMORGAN CHASE & CO, BlackRock Inc., MARSHALL WACE, LLP, and MILLENNIUM MANAGEMENT LLC.
This table shows 85 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.